Expression of pancreatic islet MHC class I, insulin, and ICA 512 tyrosine phosphatase in low-dose streptozotocin-induced diabetes in mice

Journal of Histochemistry and Cytochemistry

Volumn 48, Issue 6, 2000, Pages 761-767

  Li, Zhanchun ^a   Zhao, Lijun ^a   Sandler, Stellan ^a   Karlsson, F Anders ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes; ICA 512; Insulin; MHC class I; Pancreatic islets; Streptozotocin

Indexed keywords

INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; INSULITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ANIMALIA;

EID: 0034089474     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540004800605     Document Type: Article

References (36)

1. Andrade J, Conde M, Sobrino F, Bedoya FJ (1993) Activation of peritoneal macrophages during the prediabetic phase in low-dose streptozotocin-treated mice. FEBS Lett 327:32-34
2. Björk E, Berne C, Kämpe O, Wibell L, Oskarsson P, Karlsson FA (1996) Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes 45:1427-1430
3. Bonfanti R, Bazzigaluppi E, Calori G, Riva MC, Viscardi MC, Bognetti E, Meschi F, Bosi E, Chiumell G, Bonifacio E (1998) Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type I diabetes mellitus. Diabet Med 15:844-850
4. + T cells with Drosophila cell transfectants as antigen presenting cells. Immunol Rev 165:249-265
5. Campbell IL, Oxbrow L, Koulmanda M, Harrison LC (1988) IFN-gamma induces islet cell MHC antigen and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol 140:1111-1116
6. Cockfield SM, Ramassar V, Urmson J, Halloran PF (1989) Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma. J Immunol 142: 1120-1128
7. Foulis AK (1996) The pathology of the endocrine pancreas in type 1 (insulin-dependent) diabetes mellitus. APMIS 104:161-167
8. Furuta M, Yano H, Zhou A, Rouille Y, Holst JJ, Carroll R, Ravazzola M, Orci L, Furuta H, Steiner DF (1997) Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA 94:6646-6651
9. Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EA, Bottazzo GF (1992) Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:385-388
10. Guillam MT, Hummler E, Schaerer E, Yeh JI, Birnbaum MJ, Schmidt A, Deriaz N, Thorens B (1997) Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nature Genet 17:327-330
11. Hanninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O (1992) Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90:1901-1910
12. Hatamori N, Yokono K, Hayakawa M, Taki T, Ogawa W, Nagata M, Hari J, Shii K, Taniguchi H, Baba S (1990) Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice. Diabetologia 33:266-271
13. Huang X, Yuan J, Goddard A, Foulis FA, James RF, Lernmark A, Pujol-Borell R, Rabinovitch A, Somoza N, Stewart TA (1995) Interferon expression in the pancreases of patients with type I diabetes. Diabetes 44:658-664
14. Ihm SH, Lee KU, Rhee BD, Min HK (1990) Initial role of macrophage in the development of anti-beta-cell cellular autoimmunity in multiple low-dose streptozotocin-induced diabetes in mice. Diabetes Res Clin Pract 10:123-126
15. Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M, Kawata S, Tarui S, Kono N, Matsuzawa Y (1993) Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 92:2313-2322
16. Kolb H (1987) Mouse models of insulin dependent diabetes: low-dose streptozotocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab Rev 3:751-778
17. Kolb-Bachofen V, Epstein S, Kiesel U, Kolb H (1988) Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulins before diabetes onset. Diabetes 37:21-27
18. Kullin M, Li ZC, Björk E, Sandler S, Karlsson FA (1998) Diazoxide modifies streptozotocin induced beta-cell damage. Diabetologia 41(suppl 1):A160
19. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, Kolb H (1993) Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341:1243-1244
20. Li Z, Karlsson FA, Sandler S (in press) Alpha-cell expansion in Type 1 diabetes induced by low-dose streptozotocin in mice. J Endocrinol
21. Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415-417
22. Lukic ML, Stosic-Grujicic S, Shahin A (1998) Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev Immunol 6: 119-128
23. Mandrup-Poulsen T, Helqvist S, Wogensen LD, Mlvig J, Pociot F, Johannesen J, Nerup J (1990) Cytokines and free radicals as effector molecule in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol 164:169-193
24. McEvoy RC, Andersson J, Sandler S, Hellerström C (1984) Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. J Clin Invest 74:715-722
25. Mehta V, Palmer JP (1996) The natural history of the IDDM process. In Palmer JP, ed. Prediction, Prevention and Genetic Counseling in IDDM. Chichester, UK, John Wiley & Sons, 3-16
26. Naserke HE, Ziegler AG, Lampasona V, Bonifacio E (1998) Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J Immunol 161:6963-6969
27. Oschilewski M, Schwab E, Kiesel U, Opitz U, Stunkel K, Kolb-Bachofen Y, Kolb H (1986) Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin-induced diabetes in mice. Immunol Lett 12: 289-294
28. Sabbah E, Savola K, Kulmala P, Veijola R, Vahsalo P, Karjalainen J, Åkerbom H, Knip M (1999) The Childhood Diabetes in Finland Study Group. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type I diabetes. J Clin Endocrinol Metab 84:1534-1539
29. Sandler S, Andersson A (1981) Islet implantation into diabetic mice with pancreatic islets. Acta Pathol Microbiol Scand [A] 89:107-112
30. Solimena M, Dirkx R Jr, Hermel JM, Pleasic-Williams S, Shapiro JA, Caron L, Rabin DU (1996) ICA 512, an autoantigen of type 1 diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J 15:2102-2114
31. Sutherland DER, Goetz FC, Sibley RK (1989) Recurrence of disease in pancreas transplants. Diabetes 38:85-87
32. Unger R, Orci L (1990) Glucagon secretion in diabetes mellitus. In Rifkin H, Porte D Jr, eds. Diabetes Mellitus: Theory and Practice. 4th ed. New York, Elsevier Science, 118-120
33. Vialettes B, Maraninchi D, San Marco MP, Birg F, Stoppa AM, Mattei-Zvaco C, Thivolet C, Hermitte L, Vague P, Mercier P (1993) Autoimmune polyendocrine failure-type (insulin-dependent) diabetes mellitus and hypothyroidism-after allogeneic bone marrow transplantation in a patient with lymphoblastic leukemia. Diahetologia 36:541-546
34. Wegmann DR (1996) The immune response to islets in experimental diabetes and insulin-dependent diabetes. Curr Opin Immunol 8:860-864
35. Weiss RB (1982) Streptozotocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat Rep 66:427-438
36. Zinkernagel RM, Doherty PC (1997) The discovery of MHC restriction. Immunol Today 18:14-17